Alimera Q4 net revenue +88% to $26.3M, positive EBITDA; guides >$105M for 2024; expands credit line by $5M

ALIMERA SCIENCES INC

Q4 net revenue $26.3M (+88% YoY); full year $80.8M (+49%); net loss flat at $3.8M.
Q4 adjusted EBITDA positive $5.0M vs $(1.2M) loss YoY; full year $8.7M vs $(7.9M) loss.
Raises 2024 revenue guidance to >$105M and expects >20% adjusted EBITDA margin.
U.S. net revenue $19.2M (+104%) driven by YUTIQ; international $7.1M (+52%).
Amended loan facility: increased from $67.5M to $72.5M, $5M term loan funded; maturity April 2028.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ALIMERA SCIENCES INC reported the fourth quarter and full year ended December 31, 2023 results: revenue Net revenue of $26.3 million up 88% vs. fourth quarter of 2022, net income Net loss of $3.8 million consistent with fourth quarter of 2022. Guidance raised.

Period: the fourth quarter and full year ended December 31, 2023
Revenue: Net revenue of $26.3 million up 88% vs. fourth quarter of 2022
Net income: Net loss of $3.8 million consistent with fourth quarter of 2022
Guidance: raised
Result: reported results

Exact text from the filing

On March 7, 2024, Alimera issued a press release regarding its results of operations and financial condition for the fourth quarter and full year ended December 31, 2023 as well as recent corporate highlights.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ALIMERA SCIENCES INC amended Seventh Amendment with SLR Capital Partners, LLC (effective 2024-03-06).

Action: amendment
Agreement: credit facility
Counterparty: SLR Capital Partners, LLC
Effective: 2024-03-06

Exact text from the filing

On March 6, 2024, Alimera Sciences, Inc. (“Alimera”) entered into the Seventh Amendment (the “Amendment”) to its Loan and Security Agreement dated December 31, 2019, with SLR Capital Partners, LLC (“SLR”) as collateral agent, and the lenders party thereto

View on SEC.gov

323 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001267602-24-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.